Literature DB >> 20074473

Sublingual immunotherapy affects specific antibody and TGF-beta serum levels in patients with allergic rhinitis.

G Ciprandi1, M De Amici, M A Tosca, A Pistorio, G L Marseglia.   

Abstract

Allergic rhinitis (AR) is characterized by Th2 polarized immune response, such as increased IL-4 and reduced IFN-gamma production. Sublingual allergen-specific immunotherapy (SLIT) induces several immunological changes, most of which are still little known. The aim of this study is firstly to investigate the changes of allergen-specific IgE, IgG, IgG4, and IgA serum levels after SLIT. Secondly, this study aims at relating immunoglobulin (Ig) values with some Th1-, Th2-, and Treg-dependent cytokines. Twenty-three patients with pollen-induced AR were enrolled, and they assumed two pre-seasonal SLIT courses for 2 years. Serum allergen-specific IgE, IgG, IgG4 and IgA levels were determined by ELISA method at baseline and after each SLIT course. Serum IL-4, IFN-gamma, IL-10, and TGF-beta levels were also assessed. Allergen-specific IgE, IgG, IgG4, and IgA serum levels significantly increased after SLIT. Serum TGF-beta significantly increased after SLIT. There was a significant correlation between IgA and TGF-beta, both after the first and the second SLIT course. In conclusion, the present study provides the first evidence that pollen SLIT significantly affects Ig production, mainly concerning IgA; and IgA increase is related with TGF-beta production. Moreover, this is the first study that measured Ig classes by using a quantitative method.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20074473     DOI: 10.1177/039463200902200425

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  6 in total

1.  Sublingual immunotherapy in patients with allergic rhinoconjunctivitis.

Authors:  Deborah Gentile; David P Skoner
Journal:  Curr Allergy Asthma Rep       Date:  2011-04       Impact factor: 4.806

Review 2.  Mechanisms of tolerance induction in allergic disease: integrating current and emerging concepts.

Authors:  J Wisniewski; R Agrawal; J A Woodfolk
Journal:  Clin Exp Allergy       Date:  2013-02       Impact factor: 5.018

3.  Sublingual Immunotherapy for Asthma: Affects T-Cells but Does not Impact Basophil Activation.

Authors:  Olga Ciepiela; Anna Zawadzka-Krajewska; Iwona Kotuła; Frans van Overveld; Marek Kulus; Urszula Demkow
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-03-01       Impact factor: 1.349

4.  Oral delivery of a probiotic induced changes at the nasal mucosa of seasonal allergic rhinitis subjects after local allergen challenge: a randomised clinical trial.

Authors:  Kamal Ivory; Andrew M Wilson; Prasanna Sankaran; Marta Westwood; Justin McCarville; Claire Brockwell; Allan Clark; Jack R Dainty; Laurian Zuidmeer-Jongejan; Claudio Nicoletti
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

5.  Allergic Rhinitis and Its Relationship with IL-10, IL-17, TGF-β, IFN-γ, IL 22, and IL-35.

Authors:  P Bayrak Degirmenci; S Aksun; Z Altin; F Bilgir; I B Arslan; H Colak; B Ural; D Solakoglu Kahraman; G Diniz; B Ozdemir; C Kırmaz
Journal:  Dis Markers       Date:  2018-03-06       Impact factor: 3.434

6.  Tregitope-linked Refined Allergen Vaccines for Immunotherapy in Cockroach Allergy.

Authors:  Pannathee Prangtaworn; Urai Chaisri; Watee Seesuay; Kodchakorn Mahasongkram; Nattawat Onlamoon; Onrapak Reamtong; Anchalee Tungtrongchitr; Nitaya Indrawattana; Wanpen Chaicumpa; Nitat Sookrung
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.